PDS0101: Clinical Trials

4 trials of PDS0101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 withdrawn. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 2, Completed 1, Withdrawn 1
Phase 12Active not recruiting 1, Completed 1

Follow PDS0101: new trials by email Literature Review of PDS0101 trials Research Report on PDS0101

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
PDS0101 - HPV Associated Cancers, HIV (Human Immunodeficiency Virus)
Phase 2WithdrawnUniversity of California, San Diego2026-04-302026-08-19
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Pembrolizumab, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma
Phase 1 / Phase 2Active not recruitingMayo Clinic202022-06-162026-10-07
A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial
Cisplatin, Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Radiation Therapy - Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018
Phase 2Active not recruitingM.D. Anderson Cancer Center222020-10-142026-04-15
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
PDS0101, M7824, NHS-IL12 - Cervical Cancer, HPV Cancers
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)512020-06-092026-06-30

Conditions studied

Anus Neoplasms (2)  ·  Oropharyngeal Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Carcinoma (1)  ·  Rectal Neoplasms (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  University of California, San Diego (1)

Countries

United States (4)  ·  Puerto Rico (1)

Top investigators

Ann H Klopp (1)  ·  Charalampos Floudas, M.D. (1)  ·  David M. Routman, M.D. (1)  ·  Timothy Wilkin, MD, MPH (1)

Results publications

PMID 39976981

NIH funding

U24CA275417 (1), UG1CA275414 (1), UG1CA284883 (1), UG1CA284884 (1)